REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmally International Holding Co., Ltd (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pharmally International Holding Co., Ltd Profile Updated: August 03, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2019 Available in: English & Chinese Download a sample report

Pharmally International Holding, through Six An Huayuan Pharmaceutical Co., Ltd. as is the Company's production base, is a pharmaceutical company which develops and produces bulk drugs and infusion products. The Company was incorporated in 2013 and is headquartered in Taiwan.

Headquarters
5F.-1, No. 10, Ln. 5, Linsen N. Rd., Zhongzheng Dist., Taipei
Taipei City; Taipei City;

Contact Details: Purchase the Pharmally International Holding Co., Ltd report to view the information.

Website: http://www.pharmally.com

Basic Information
Total Employees:
Purchase the Pharmally International Holding Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Pharmally International Holding Co., Ltd report to view the information.
Financial Auditors:
Purchase the Pharmally International Holding Co., Ltd report to view the information.
Incorporation Date:
November 07, 2013
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
President
Purchase this report to view the information.
Spokesperson
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Kang You invest Co., Ltd. Philippines
100%
KangYou investment company
100%
Longterm Lista
100%
Company Performance
Financial values in the chart are available after Pharmally International Holding Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-1.97%
Total operating revenue
-1.97%
Operating profit (EBIT)
2.56%
EBITDA
-31.76%
Net Profit (Loss) for the Period
-46.12%
Total assets
-2.95%
Total equity
-0.82%
Operating Profit Margin (ROS)
1.16%
Net Profit Margin
-10.07%
Return on Equity (ROE)
-1.43%
Debt to Equity Ratio
-1.42%
Quick Ratio
0.95%
Cash Ratio
0.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?